Gilead Sciences Newsroom

Gilead Sciences Analyst Ratings

BenzingaJul 1 10:01 ET

Gilead Sciences (GILD) Receives a Hold From RBC Capital

TipRanksJul 1 06:37 ET

Redburn Atlantic Adjusts Price Target on Gilead Sciences to $119 From $117

MT NewswiresJun 26 06:45 ET

Gilead Sciences Analyst Ratings

BenzingaJun 20 13:41 ET

What 8 Analyst Ratings Have To Say About Gilead Sciences

BenzingaJun 14 12:03 ET

Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Gilead Sciences (GILD) and Sanofi (OtherSNYNF)

TipRanksMay 31 05:52 ET

Hold Rating on Gilead Sciences Amid Trodelvy Trial Setbacks and Future Uncertainties

TipRanksMay 31 05:48 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Gilead Sciences (GILD), Biogen (BIIB) and Argenx Se (ARGX)

TipRanksMay 30 23:04 ET

Analysts' Top Healthcare Picks: Scholar Rock Holding (SRRK), Gilead Sciences (GILD)

TipRanksMay 23 07:25 ET

Gilead Sciences (GILD) Gets a Hold From Wells Fargo

TipRanksMay 22 05:45 ET

Analysts' Top Healthcare Picks: Bio-Techne (TECH), Gilead Sciences (GILD)

TipRanksMay 2 09:45 ET

Redburn Atlantic Adjusts Price Target on Gilead Sciences to $117 From $120

MT NewswiresMay 1 08:27 ET

Gilead Sciences: Hold Rating Justified Amid Stable Outlook and Upcoming Oncology Catalysts

TipRanksApr 30 07:02 ET

Analysts Conflicted on These Healthcare Names: Annovis Bio (ANVS), Gilead Sciences (GILD) and Omega Therapeutics (OMGA)

TipRanksApr 30 06:35 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Teladoc (TDOC), R1 RCM (RCM) and Gilead Sciences (GILD)

TipRanksApr 30 02:55 ET

Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Gilead Sciences (GILD) and Sanofi (OtherSNYNF)

TipRanksApr 30 02:35 ET

Gilead Sciences Analyst Ratings

BenzingaApr 29 11:31 ET

Gilead Sciences: Hold Rating With Cautious Outlook Amidst Market Challenges and Growth Uncertainties

TipRanksApr 29 05:51 ET

Analysts Are Neutral on These Healthcare Stocks: Edwards Lifesciences (EW), Gilead Sciences (GILD)

TipRanksApr 27 00:20 ET

Morgan Stanley Adjusts Price Target on Gilead Sciences to $78 From $80

MT NewswiresApr 26 10:05 ET